Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Diabetes Complications. 2016 Apr 13;30(6):1103–1110. doi: 10.1016/j.jdiacomp.2016.04.008

Table 1.

Differences in clinical parameters between controls and adolescents with T1D.

Type 1 Diabetes (N=41) Controls (N=48) P-value
Age (years) 15.0 ± 1.9 15.1 ± 2.1 0.80
Sex (% female) 54% 67% 0.21
BMI percentile 58±27 57±22 0.78
BMI z-score* 0.5 (−0.2–0.9) 0.4 (−0.2–0.8) 0.79
Lean mass (kg) 44.1 ± 7.7 39.5 ± 8.4 0.01
Fat mass (kg) 15.7 ± 7.8 18.0 ± 14.7 0.38
Tanner stage* 4.5 (4–5) 4.0 (4–5) 0.48
Diabetes Duration (years)* 4.6 (1.7–7.8)
HbA1c (%) 8.3 ± 1.4 5.2 ± 0.3 <0.0001
Leptin (ng/mL)* 13.1 (5.8–16.4) 10.1 (3.4–13.4) 0.09
Adiponectin (μg/mL) 11.5 ± 6.0 9.0 ± 3.4 0.02
Physical Activity (METs) 63.8 ± 11.8 59.5 ± 13.6 0.15
Heart Rate (min−1) 67 ± 13 67 ± 24 0.94
Resting systolic blood pressure (mmHg) 116 ± 12 112 ± 8 0.08
Resting diastolic blood pressure (mmHg) 67 ± 8 66 ± 7 0.45

Data presented as mean and SD unless otherwise specified.

*

Median, P25–P75.